AR and polycystic ovary syndrome: Transgenic silencing of AR actions in the brain in peripubertal DHT-induced experimental PCOS mice either fully or partially prevent the development of most reproductive and metabolic PCOS traits normally observed, including ovulatory dysfunction, polyfollicular ovaries, adiposity, adipocyte hypertrophy, dyslipidemia, and hepatic steatosis (124).